National Health Investors, Inc. (NYSE:NHI) Receives $87.50 Consensus PT from Analysts

National Health Investors, Inc. (NYSE:NHI) has been given an average rating of “Moderate Buy” by the seven research firms that are covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $86.6667.

Several equities research analysts have recently issued reports on the stock. Weiss Ratings reiterated a “buy (b)” rating on shares of National Health Investors in a research report on Friday, March 27th. Truist Financial reduced their price objective on shares of National Health Investors from $92.00 to $89.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Cantor Fitzgerald reiterated an “overweight” rating and set a $94.00 price objective on shares of National Health Investors in a research report on Wednesday, April 22nd. Finally, Wells Fargo & Company reduced their price objective on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a research report on Monday, June 1st.

Insider Activity

In related news, CEO D. Eric Mendelsohn acquired 1,500 shares of National Health Investors stock in a transaction dated Friday, June 5th. The shares were purchased at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the transaction, the chief executive officer directly owned 133,316 shares in the company, valued at approximately $9,177,473.44. This represents a 1.14% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 2.70% of the stock is currently owned by insiders.

Institutional Investors Weigh In On National Health Investors

Several institutional investors and hedge funds have recently modified their holdings of the stock. International Assets Investment Management LLC purchased a new position in shares of National Health Investors in the fourth quarter valued at $27,000. EverSource Wealth Advisors LLC grew its holdings in shares of National Health Investors by 244.1% in the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after purchasing an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC purchased a new position in shares of National Health Investors in the fourth quarter valued at $33,000. GAMMA Investing LLC grew its holdings in shares of National Health Investors by 41.8% in the fourth quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock valued at $35,000 after purchasing an additional 136 shares in the last quarter. Finally, Key Capital Management INC purchased a new position in shares of National Health Investors in the fourth quarter valued at $47,000. Institutional investors own 62.51% of the company’s stock.

National Health Investors Price Performance

NYSE NHI opened at $70.35 on Friday. National Health Investors has a 12 month low of $67.94 and a 12 month high of $91.38. The stock has a market cap of $3.41 billion, a price-to-earnings ratio of 22.69, a PEG ratio of 3.68 and a beta of 0.52. The company’s 50 day moving average is $78.33 and its two-hundred day moving average is $80.31. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83.

National Health Investors (NYSE:NHI) last released its earnings results on Monday, May 4th. The real estate investment trust reported $0.82 EPS for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.39). National Health Investors had a return on equity of 9.82% and a net margin of 36.86%.The firm had revenue of $115.13 million for the quarter, compared to the consensus estimate of $70.22 million. During the same quarter in the previous year, the business posted $1.15 EPS. National Health Investors’s revenue was up 28.9% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, research analysts anticipate that National Health Investors will post 5.07 earnings per share for the current year.

National Health Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.92 per share. The ex-dividend date is Tuesday, June 30th. This represents a $3.68 annualized dividend and a dividend yield of 5.2%. National Health Investors’s dividend payout ratio (DPR) is presently 118.71%.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.